Sunflower Therapeutics secures a $2.36 million NIH SBIR grant to develop a continuous cell disruption platform for VLP-based vaccine manufacturing, aiming to enhance production efficiency.
Amount Raised
$2.36 Million
Round Type
Grant
MedfordBiotechnologyInvestors
Description
Sunflower Therapeutics has received a Small Business Innovation Research (SBIR) grant of up to $2.36 million from NIH. The funding will support the development of an automated platform to improve the production of virus-like particles for vaccines. Initial funding of $300,000 will be provided, with more available upon hitting milestones. This grant is a step towards making vaccine manufacturing more efficient and cost-effective.
Who to call at Sunflower Therapeutics, and when
A new round usually means Sunflower Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Sunflower Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Sunflower Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Sunflower Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Sunflower Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Sunflower Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.